Dutch medtech startup developing a non-invasive haemoglobin measurement device using PPG and AI.
| Date | Round | Amount |
|---|---|---|
| Sep 2022 | Grant Amsterdam medtech Sanguis.ai received a 19.2K euro MIT feasibility phase-1 grant via Provincie Noord-Holland to test its non-invasive haemoglobin-measurement prototype. | $19.2K |